Literature DB >> 12220528

Accelerated degradation of mislocalized UDP-glucuronosyltransferase family 1 (UGT1) proteins in Gunn rat hepatocytes.

Yoshikazu Emi1, Satoshi Omura, Shin-ichi Ikushiro, Takashi Iyanagi.   

Abstract

Gunn rat is a hyperbilirubinemic rat strain that is inherently deficient in the activity of UDP-glucuronosyltransferase form 1A1 (UGT1A1). A premature termination codon is predicted to produce truncated UGT1 proteins that lack the COOH-terminal 116 amino acids in Gunn rat. Pulse-chase experiments using primary cell cultures showed that the truncated UGT1A1 protein in Gunn rat hepatocytes was synthesized similarly to wild-type UGT1A1 protein in normal Wistar rat hepatocytes. However, the truncated UGT1A1 protein was degraded rapidly with a half-life of about 50 min, whereas the wild-type UGT1A1 protein had a much longer half-life of about 10 h. The rapid degradation of truncated UGT1A1 protein was inhibited partially but not completely by treating Gunn rat hepatocytes with proteasome inhibitors such as carbobenzoxy-Leu-Leu-leucinal and lactacystin. By contrast, neither the lysosomal cysteine protease inhibitor nor the calpain inhibitor slowed the degradation. Our findings show that the absence of UGT1 protein from Gunn rat hepatocytes is due to rapid degradation of the truncated UGT1 protein by the proteasome and elucidate the molecular basis underlying the deficiency in bilirubin glucuronidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220528     DOI: 10.1016/s0003-9861(02)00351-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer.

Authors:  Giulia Bortolussi; Lorena Zentilin; Gabriele Baj; Pablo Giraudi; Cristina Bellarosa; Mauro Giacca; Claudio Tiribelli; Andrés F Muro
Journal:  FASEB J       Date:  2011-11-17       Impact factor: 5.191

2.  Truncated UDP-glucuronosyltransferase (UGT) from a Crigler-Najjar syndrome type II patient colocalizes with intact UGT in the endoplasmic reticulum.

Authors:  Masahiro Suzuki; Marie Hirata; Miho Takagi; Taiichi Watanabe; Tomohiro Iguchi; Kotaro Koiwai; So Maezawa; Osamu Koiwai
Journal:  J Hum Genet       Date:  2014-01-09       Impact factor: 3.172

3.  Generation of Ugt1-deficient murine liver cell lines using TALEN technology.

Authors:  Fabiola Porro; Luka Bockor; Alessia De Caneva; Giulia Bortolussi; Andrés F Muro
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

4.  Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.

Authors:  Fabiola Porro; Giulia Bortolussi; Adi Barzel; Alessia De Caneva; Alessandra Iaconcig; Simone Vodret; Lorena Zentilin; Mark A Kay; Andrés F Muro
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

5.  Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.

Authors:  Alexander F Flynn; M Gordon Joyce; Rebekah T Taylor; Sasisekhar Bennuru; Alyssa R Lindrose; Spencer L Sterling; C Paul Morris; Thomas B Nutman; Edward Mitre
Journal:  PLoS Negl Trop Dis       Date:  2019-09-12

6.  Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.

Authors:  Joshua F Apgar; Jian-Ping Tang; Pratap Singh; Nanda Balasubramanian; John Burke; Michael R Hodges; Melissa A Lasaro; Lin Lin; Bjorn L Millard; Kristi Moore; Lucy S Jun; Susan Sobolov; Anna Katharina Wilkins; Xiang Gao
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.